Measures of success: How value-based pricing may change the pharmaceutical industry
The Biggest Obstacle to Value-Based Care
The Office of Inspector General (OIG) and the Centers for Medicare & Medicaid Services (CMS) jointly published final rules that expand upon and modify regulatory safe harbors and exceptions to the Anti-Kickback Statute and...more